全文获取类型
收费全文 | 4459篇 |
免费 | 198篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 100篇 |
妇产科学 | 42篇 |
基础医学 | 493篇 |
口腔科学 | 133篇 |
临床医学 | 289篇 |
内科学 | 934篇 |
皮肤病学 | 59篇 |
神经病学 | 352篇 |
特种医学 | 172篇 |
外国民族医学 | 1篇 |
外科学 | 930篇 |
综合类 | 8篇 |
预防医学 | 104篇 |
眼科学 | 76篇 |
药学 | 366篇 |
中国医学 | 5篇 |
肿瘤学 | 613篇 |
出版年
2023年 | 28篇 |
2022年 | 40篇 |
2021年 | 93篇 |
2020年 | 52篇 |
2019年 | 63篇 |
2018年 | 86篇 |
2017年 | 64篇 |
2016年 | 86篇 |
2015年 | 80篇 |
2014年 | 132篇 |
2013年 | 157篇 |
2012年 | 198篇 |
2011年 | 203篇 |
2010年 | 161篇 |
2009年 | 112篇 |
2008年 | 219篇 |
2007年 | 234篇 |
2006年 | 190篇 |
2005年 | 188篇 |
2004年 | 181篇 |
2003年 | 180篇 |
2002年 | 151篇 |
2001年 | 123篇 |
2000年 | 122篇 |
1999年 | 114篇 |
1998年 | 46篇 |
1997年 | 40篇 |
1996年 | 48篇 |
1995年 | 36篇 |
1994年 | 34篇 |
1993年 | 48篇 |
1992年 | 95篇 |
1991年 | 101篇 |
1990年 | 101篇 |
1989年 | 98篇 |
1988年 | 89篇 |
1987年 | 90篇 |
1986年 | 79篇 |
1985年 | 80篇 |
1984年 | 51篇 |
1983年 | 45篇 |
1982年 | 24篇 |
1979年 | 32篇 |
1978年 | 20篇 |
1977年 | 22篇 |
1975年 | 22篇 |
1974年 | 22篇 |
1971年 | 24篇 |
1969年 | 20篇 |
1968年 | 21篇 |
排序方式: 共有4686条查询结果,搜索用时 31 毫秒
101.
Yuko Kitagawa Hitoshi Idani Haruhiro Inoue Harushi Udagawa Ichiro Uyama Harushi Osugi Natsuya Katada Hiroya Takeuchi Yasunori Akutsu Shinya Asami Ken Ishikawa Akihiko Okamura Taiki Ono Fumihiko Kato Toshiki Kawabata Koichi Suda Tomoko Takesue Tsuyoshi Tanaka Mai Tsutsui Kei Hosoda Satoru Matsuda Tatsuo Matsuda Mariko Mani Tatsuya Miyazaki 《Asian journal of endoscopic surgery》2015,8(2):114-124
102.
103.
104.
105.
Shoichiro Sumi MD Dr. Kazutomo Inoue MD Masafumi Kogire MD Ryuichiro Doi MD Mitsutoshi Yun MD Hiromu Kaji MD Ryo Hosotani MD Masaki Fujimura MD Kotaro Uchida MD Shinya Kiyama PhD Kouki Kitagawa PhD Haruaki Yajima PhD Nobutaka Fujii PhD Takayoshi Tobe MD 《Digestive diseases and sciences》1991,36(11):1523-1528
This study examined the effect of synthetic porcine neuropeptide Y on the splanchnic blood flows and the exocrine pancreatic secretion in dogs. Graded doses of neuropeptide Y (0.1–5 g/kg, intravenous) caused dose-dependent reduction of the secretin-stimulated exocrine pancreatic secretion and of the blood flows in the superior mesenteric artery, the portal vein, and the pancreatic tissue. Neuropeptide Y at 5 g/kg reduced the blood flows to 45.9±13.3% (superior mesenteric artery), 63.0±10.5% (portal vein), and 77.9±4.8% (pancreatic tissue), respectively. This dose also reduced secretin-stimulated pancreatic juice volume and CCK-8 plus secretin-stimulated protein output to 65.2±9.3 and 63.3±14.0%, respectively. This study shows a potent vasoconstrictor effect of neuropeptide Y on splanchnic vessels. Neuropeptide Y also inhibited exocrine pancreatic secretion in a significant correlation with the reduction in pancreatic tissue blood flow, which suggests that reduction in the blood flow may be one of the possible mechanisms of the inhibitory action of neuropeptide Y on exocrine secretion.This work was supported by a grant from the Ministry of Education, Japan (A-61440060). 相似文献
106.
107.
Hara A Wada T Kitajima S Toyama T Okumura T Kitagawa K Iwata Y Sakai N Furuichi K Higuchi M Kaneko S 《American journal of hematology》2008,83(9):750-752
A 42-year-old woman with systemic lupus erythematosus was admitted to our hospital because of severe anemia. Her bone marrow was almost normocellular and erythroblasts were nearly absent. Laboratory data showed elevated levels of lactate dehydrogenase and positive findings on Coombs' tests. On the basis of these findings, her anemia was diagnosed as the overlap of pure red cell aplasia with autoimmune hemolytic anemia. Radioimmunoprecipitation assay revealed that her serum was positive for anti-erythropoietin antibodies before therapy. Furthermore, the autoantibodies inhibited proliferation of an erythropoietin-dependent cell line in a dose-dependent manner. Immunosuppressive treatment improved the anemia accompanied with disappearance of the autoantibodies. 相似文献
108.
Tomohiro Sakamoto Sunao Kojima Hisao Ogawa Hideki Shimomura Kazuo Kimura Yasuhiro Ogata Naritsugu Sakaino Akira Kitagawa 《Circulation journal》2007,71(9):1348-1353
BACKGROUND: Statins are widely used to reduce blood levels of low-density lipoprotein-cholesterol (LDL-C). Each statin has unique pharmacokinetic properties; lipophilicity is one such property and relates to tissue selectivity. METHODS AND RESULTS: The Multicenter Study for Aggressive Lipid-lowering Strategy by HMG-CoA Reductase Inhibitors in Patients with Acute Myocardial Infarction (MUSASHI-AMI) trial evaluated the effect of discretional statin treatment initiated within 96 h after onset of acute myocardial infarction (AMI) in Japanese patients. To clarify whether statin lipophilicity affects prognosis, a post hoc analysis of the MUSASHI-AMI database was performed. Patients who were assigned to receive statin were separated into 2 groups according to the lipophilicity of the statins they were administered: lipophilic statins (atorvastatin, fluvastatin, pitavastatin and simvastatin; LS group; n=131) or hydrophilic statins (pravastatin; HS group; n=110). There was no difference in baseline LDL-C concentrations between the 2 groups. Although LDL-C was decreased more potently in the LS than HS groups (-34% vs -19%; p=0.0069), acute coronary syndrome events tended to occur less frequently (3.6% vs 9.9%; p=0.0530) and the incidence of new Q-wave appearance in electrocardiogram was significantly lower (75% vs 89%; p=0.0056) in the HS than LS groups. CONCLUSIONS: In normocholesterolemic Japanese patients after AMI, hydrophilic pravastatin could be superior to lipophilic statins at preventing new Q-wave appearance and reducing cardiovascular events. 相似文献
109.
Yagi S Akaike M Fujimura M Ise T Yoshida S Sumitomo Y Ikeda Y Iwase T Aihara K Azuma H Kurushima A Ichikawa Y Kitagawa T Kimura T Nishiuchi T Matsumoto T 《Internal medicine (Tokyo, Japan)》2008,47(12):1113-1116
Lactobacillus (LB) is a gram-positive rod-shaped bacterium that inhabits the oral cavity, gastrointestinal tract, vagina and nasal cavity. Although LB plays a role in the prevention of infections caused by pathogenic bacteria, it causes some critical infectious diseases such as infective endocarditis (IE). IE due to LB is rare; however, early diagnosis and early treatment are important because of its high mortality rate. We report the onset of IE after otologic treatment in a heavy drinker of alcohol, the second case of IE due to LB in Japan. 相似文献
110.
I. Ninomiya H. Osugi T. Fujimura S. Fushida K. Okamoto S. Maruzen K. Oyama J. Kinoshita T. Tsukada H. Kitagawa H. Takamura H. Nakagawara H. Tajima H. Hayashi I. Makino T. Ohta 《Diseases of the esophagus》2014,27(2):159-167
The aim of this study was to estimate the technical and oncologic feasibility of video‐assisted thoracoscopic radical esophagectomy (VATS) in the left lateral position. From January 2003 to December 2011, 132 patients with esophageal cancer underwent VATS. The mean duration of the thoracic procedure and the entire procedure was 294 ± 88 and 623 ± 123 minutes, respectively. Mean blood loss during the thoracic procedure and the entire procedure was 313 ± 577 and 657 ± 719 g, respectively. The mean number of dissected thoracic lymph nodes was 32.6 ± 12.9. There were four in‐hospital deaths (3.0%); two patients (1.5%) died of acute respiratory distress syndrome and two patients (1.5%) died of tumor progression. Postoperative unilateral or bilateral recurrent laryngeal nerve (RLN) palsy, or pneumonia was found in 33 (25.0%), 21 (15.9%), and 27(20.5%) patients, respectively. The patients were divided into the first 66 patients who underwent VATS (Group 1) and the subsequent 66 patients (Group 2). The numbers of cases who underwent neoadjuvant or induction chemotherapy for T4 tumor and intrathoracic anastomosis were higher in Group 2 than in Group 1. The duration of the procedure, amount of blood loss, and the number of dissected thoracic lymph nodes were not different between the two groups. The total number of dissected lymph nodes was higher in Group 2 than in Group 1 (72.6 ± 27.8 vs. 62.6 ± 21.6, P = 0.023). The rate of bilateral RLN palsy was less in Group 2 than in Group 1 (7.6% vs. 24.2%, P = 0.042). The mean follow‐up period was 38.7 months. Primary recurrence consisted of hematogenous, lymphatic, peritoneal dissemination, pleural dissemination, and locoregional in 15 (11.3%), 20 (15.1%), 3 (2.3%), 4 (3.0%), and 5 patients (3.8%), respectively. The rate of regional lymph node recurrence within the dissection field was only 4.5%. The prognosis of patients with lymph node metastasis was significantly poorer than that of patients without lymph node metastasis. However, the prognosis of the 11 cases that had metastasis only around RLNs was similar to that of node‐negative cases. Thirteen patients with pathological remnant tumor (R1 or R2) did not survive longer than 5 years at present. The overall 5‐year survival rate of stage I, II, and III disease after curative VATS was 82.2%, 77.0%, and 52.3%, respectively. Expansion of VATS criteria for patients after induction chemotherapy for T4 tumor or thoracoscopic anastomosis did not adversely affect the surgical results by experience. Although the VATS procedure is accompanied by a certain degree of morbidity including RLN palsy and pulmonary complications, VATS has an excellent locoregional control effect. In addition, the favorable survival after VATS shows that the procedure is oncologically feasible. 相似文献